Variant report

Variant	nsv564346
Chromosome Location	chr14:36988010-36989849
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr14:36989745-36989957	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD2	chr14:36989086-36989413	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTBP2	chr14:36987100-36990550	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr14:36989815-36990135	K562	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
5	CTCF	chr14:36989380-36989530	HEK293	kidney:	n/a	n/a
6	CTCF	chr14:36989800-36989950	GM12872	blood:	n/a	n/a
7	CTCF	chr14:36989380-36989530	GM12871	blood:	n/a	n/a
8	CTCF	chr14:36989340-36989490	HEEpiC	esophagus:	n/a	n/a
9	CTCF	chr14:36989460-36989610	SAEC	small airway:	n/a	chr14:36989542-36989555
10	CTCF	chr14:36989840-36989990	HRE	kidney:	n/a	chr14:36989958-36989971
11	CTCF	chr14:36989844-36990114	IMR90	lung:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
12	CTCF	chr14:36989840-36989990	HPF	lung:	n/a	chr14:36989958-36989971
13	CTCF	chr14:36989727-36990250	MCF-7	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
14	CTCF	chr14:36989360-36989510	SAEC	small airway:	n/a	n/a
15	CTCF	chr14:36989838-36990086	MCF-7	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
16	CTCF	chr14:36989733-36990127	MCF-7	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
17	CTCF	chr14:36989840-36989990	NB4	blood:	n/a	chr14:36989958-36989971
18	CTCF	chr14:36989340-36989490	GM12872	blood:	n/a	n/a
19	CTCF	chr14:36989240-36989390	HAc	cerebellar:	n/a	n/a
20	CTCF	chr14:36989832-36990138	K562	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
21	CTCF	chr14:36989800-36989950	GM12866	blood:	n/a	n/a
22	CTCF	chr14:36989360-36989510	NHEK	skin:	n/a	n/a
23	CTCF	chr14:36989460-36989610	HMEC	breast:	n/a	chr14:36989542-36989555
24	CTCF	chr14:36989800-36990171	HepG2	liver:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
25	CTCF	chr14:36989840-36989990	GM12869	blood:	n/a	chr14:36989958-36989971
26	CTCF	chr14:36989469-36989529	H1-hESC	embryonic stem cell:	n/a	n/a
27	CTCF	chr14:36989826-36990093	MCF-7	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
28	CTCF	chr14:36988660-36988810	A549	lung:	n/a	n/a
29	CTCF	chr14:36989340-36989490	HUVEC	blood vessel:	n/a	n/a
30	CTCF	chr14:36989841-36990099	Gliobla	brain:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
31	CTCF	chr14:36989820-36989970	HFF	foreskin:	n/a	n/a
32	CTCF	chr14:36989840-36989990	A549	lung:	n/a	chr14:36989958-36989971
33	CTCF	chr14:36989820-36989970	HVMF	connective:	n/a	n/a
34	CTCF	chr14:36989820-36989970	BE2_C	brain:	n/a	n/a
35	CTCF	chr14:36989840-36989990	GM12868	blood:	n/a	chr14:36989958-36989971
36	CTCF	chr14:36989820-36989970	AG04450	lung:	n/a	n/a
37	CTCF	chr14:36989400-36989550	Caco-2	colon:	n/a	n/a
38	CTCF	chr14:36989840-36990095	MCF-7	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
39	CTCF	chr14:36989839-36990103	K562	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
40	CTCF	chr14:36989848-36990088	MCF-7	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
41	CTCF	chr14:36989360-36989510	Caco-2	colon:	n/a	n/a
42	CTCF	chr14:36989540-36989690	HCT-116	colon:	n/a	chr14:36989542-36989555
43	CTCF	chr14:36989184-36990314	A549	lung:	n/a	chr14:36989542-36989555 chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
44	E2F6	chr14:36989796-36990075	A549	lung:	n/a	chr14:36989958-36989968 chr14:36990013-36990025
45	EGR1	chr14:36988852-36989430	H1-hESC	embryonic stem cell:	n/a	n/a
46	EGR1	chr14:36988865-36989401	H1-hESC	embryonic stem cell:	n/a	n/a
47	EGR1	chr14:36989695-36990123	H1-hESC	embryonic stem cell:	n/a	chr14:36990036-36990049
48	EGR1	chr14:36989434-36989626	K562	blood:	n/a	chr14:36989580-36989593 chr14:36989612-36989625 chr14:36989579-36989593 chr14:36989516-36989526 chr14:36989581-36989591 chr14:36989580-36989590 chr14:36989580-36989593 chr14:36989581-36989592 chr14:36989613-36989622 chr14:36989580-36989593 chr14:36989476-36989489 chr14:36989581-36989591 chr14:36989581-36989590 chr14:36989579-36989594 chr14:36989580-36989593 chr14:36989575-36989597
49	ELF1	chr14:36989784-36990033	HepG2	liver:	n/a	n/a
50	ELF1	chr14:36989843-36990063	K562	blood:	n/a	chr14:36990038-36990047

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:36988446-36988496	HEEpiC	esophagus:	n/a
2	chr14:36988446-36988496	HEEpiC	esophagus:	n/a
3	chr14:36988805-36988855	HNPCEpiC	eye:	n/a
4	chr14:36989588-36989638	T-47D	breast:	n/a
5	chr14:36988217-36988267	HUVEC	blood vessel:	n/a
6	chr14:36988217-36988267	Caco-2	colon:	n/a
7	chr14:36989404-36989454	HEEpiC	esophagus:	n/a
8	chr14:36988805-36988855	GM06990	blood:	n/a
9	chr14:36988217-36988267	PANC-1	pancreas:	n/a
10	chr14:36989290-36989340	HRPEpiC	eye:	n/a
11	chr14:36989287-36989337	NH-A	brain:	n/a
12	chr14:36989287-36989337	GM06990	blood:	n/a
13	chr14:36989588-36989638	MCF-7	breast:	n/a
14	chr14:36988854-36988904	HRCEpiC	kidney:	n/a
15	chr14:36989454-36989504	GM12878	blood:	n/a
16	chr14:36988443-36988493	GM06990	blood:	n/a
17	chr14:36988446-36988496	AG10803	skin:	n/a
18	chr14:36988778-36988828	H1-hESC	embryonic stem cell:	embryo
19	chr14:36988443-36988493	GM19239	blood:	n/a
20	chr14:36989287-36989337	AG04450	lung:	fetal
21	chr14:36988443-36988493	AG04449	skin:	fetal
22	chr14:36988217-36988267	HCPEpiC	choroid plexus:	n/a
23	chr14:36988778-36988828	GM19239	blood:	n/a
24	chr14:36988446-36988496	Caco-2	colon:	n/a
25	chr14:36989550-36989600	K562	blood:	n/a
26	chr14:36989404-36989454	PrEC	prostate:	n/a
27	chr14:36989550-36989600	HRE	kidney:	n/a
28	chr14:36988446-36988496	HIPEpiC	eye:	n/a
29	chr14:36988854-36988904	RPTEC	kidney:	n/a
30	chr14:36988446-36988496	ProgFib	skin:	n/a
31	chr14:36989588-36989638	HCT-116	colon:	n/a
32	chr14:36989454-36989504	HMEC	breast:	n/a
33	chr14:36989588-36989638	SK-N-SH_RA	brain:	n/a
34	chr14:36989287-36989337	HCM	heart:	n/a
35	chr14:36988854-36988904	MCF10A-Er-Src	breast:	n/a
36	chr14:36989454-36989504	AoSMC	blood vessel:	n/a
37	chr14:36989287-36989337	NB4	blood:	n/a
38	chr14:36989404-36989454	SK-N-MC	brain:	n/a
39	chr14:36989454-36989504	PFSK-1	brain:	n/a
40	chr14:36989290-36989340	Jurkat	blood:	n/a
41	chr14:36989287-36989337	AoSMC	blood vessel:	n/a
42	chr14:36988778-36988828	SAEC	small airway:	n/a
43	chr14:36989588-36989638	Caco-2	colon:	n/a
44	chr14:36989404-36989454	NHDF-neo	bronchial:	n/a
45	chr14:36988217-36988267	SAEC	small airway:	n/a
46	chr14:36989588-36989638	HNPCEpiC	eye:	n/a
47	chr14:36989550-36989600	BE2_C	brain:	n/a
48	chr14:36989588-36989638	HEK293	kidney:	embryo
49	chr14:36989454-36989504	HAEpiC	amniotic membrane:	n/a
50	chr14:36988443-36988493	ECC-1	luminal epithelium:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr14:36986593..36988111-chr14:36992508..36994903,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PAX9-3	chr14:36988483-36988884	ENSG00000253563.2
2	lnc-SFTA3-1	chr14:36988673-36988726	ENSG00000257520.1

Variant related genes	Relation type
SFTA3	TF binding region
NKX2-1	TF binding region
ENSG00000257520	TF binding region
NKX2-1-AS1	TF binding region
SFTA3	CpG island
NKX2-1	CpG island
ENSG00000257520	CpG island
NKX2-1-AS1	CpG island

Extended variants
information (count: 66 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:66 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs112448937	chr14:36988110-36988111	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs570437377	chr14:36988115-36988116	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs532929714	chr14:36988127-36988128	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs113471745	chr14:36988139-36988140	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs375307385	chr14:36988141-36988142	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs367900139	chr14:36988202-36988203	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs546402304	chr14:36988348-36988349	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs566702552	chr14:36988404-36988405	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs61997695	chr14:36988418-36988419	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs535188654	chr14:36988419-36988420	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs182071645	chr14:36988454-36988455	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs201631950	chr14:36988463-36988464	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs200134608	chr14:36988465-36988466	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs200350608	chr14:36988479-36988480	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs140051139	chr14:36988484-36988485	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs200779342	chr14:36988599-36988600	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs74985314	chr14:36988605-36988606	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs147791173	chr14:36988623-36988624	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs78357041	chr14:36988635-36988636	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs542988107	chr14:36988666-36988667	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs540789636	chr14:36988668-36988669	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
22	rs554063033	chr14:36988674-36988675	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs576139973	chr14:36988697-36988698	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
24	rs574220987	chr14:36988761-36988762	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs561607086	chr14:36988763-36988764	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs542732528	chr14:36988766-36988767	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs563032142	chr14:36988802-36988803	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs374034707	chr14:36988829-36988830	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs80199574	chr14:36988919-36988920	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs77215103	chr14:36988920-36988921	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs61997696	chr14:36988922-36988923	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs149047715	chr14:36988928-36988929	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs372170273	chr14:36988929-36988930	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs575596479	chr14:36988953-36988954	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs541524052	chr14:36988997-36988998	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs565654773	chr14:36989083-36989084	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs187816600	chr14:36989091-36989092	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs563990192	chr14:36989102-36989103	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs533063532	chr14:36989115-36989116	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs193043968	chr14:36989183-36989184	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs566529892	chr14:36989188-36989189	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs529122651	chr14:36989189-36989190	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs555458391	chr14:36989203-36989204	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs201979429	chr14:36989306-36989307	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
45	rs372925758	chr14:36989325-36989326	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
46	rs375793163	chr14:36989333-36989334	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
47	rs530304913	chr14:36989336-36989337	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
48	rs568956283	chr14:36989343-36989344	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs367897299	chr14:36989353-36989354	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs537795327	chr14:36989367-36989368	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Wilms tumour	21544195	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Burkitt''s lymphoma	19759907	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21785460	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Lung cancer	17925434	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
abnormal development	18461090	CNVD
Prostate cancer	21298110	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	21858162	CNVD
Lung cancer	20031968	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21183584	CNVD
Prostate cancer	21147910	CNVD

Chromatin state (count:340 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:36981400-36991200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
2	chr14:36985400-36988200	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr14:36986400-36988200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
4	chr14:36986400-36988200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr14:36986400-36988200	Bivalent Enhancer	Esophagus	oesophagus
6	chr14:36986400-36988400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
7	chr14:36986400-36988600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
8	chr14:36986400-36989000	Bivalent Enhancer	Liver	Liver
9	chr14:36986400-36989200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr14:36986400-36989800	Enhancers	Gastric	stomach
11	chr14:36986400-36989800	Enhancers	Pancreas	Pancrea
12	chr14:36986600-36988200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
13	chr14:36986600-36988200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr14:36986600-36989400	Bivalent Enhancer	Spleen	Spleen
15	chr14:36987000-36988200	Bivalent Enhancer	Adipose Nuclei	Adipose
16	chr14:36987000-36988600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
17	chr14:36987400-36988200	Flanking Bivalent TSS/Enh	Lung	lung
18	chr14:36987400-36989400	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
19	chr14:36987600-36988200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr14:36987600-36988400	Bivalent Enhancer	Brain Cingulate Gyrus	brain
21	chr14:36987600-36988600	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
22	chr14:36987800-36988200	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
23	chr14:36987800-36988200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr14:36987800-36988200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr14:36987800-36988200	Bivalent Enhancer	Colonic Mucosa	Colon
26	chr14:36987800-36988200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
27	chr14:36987800-36988400	Bivalent Enhancer	Brain Substantia Nigra	brain
28	chr14:36987800-36988600	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr14:36987800-36989800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
30	chr14:36988000-36988200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr14:36988000-36988200	Bivalent Enhancer	Fetal Brain Female	brain
32	chr14:36988000-36988200	Bivalent/Poised TSS	NHEK	skin
33	chr14:36988000-36988400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
34	chr14:36988000-36988400	Bivalent Enhancer	Ovary	ovary
35	chr14:36988000-36988400	Bivalent Enhancer	HMEC	breast
36	chr14:36988000-36988600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
37	chr14:36988000-36988600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr14:36988000-36988600	Bivalent Enhancer	Fetal Brain Male	brain
39	chr14:36988000-36988600	Flanking Bivalent TSS/Enh	Right Ventricle	heart
40	chr14:36988000-36988600	Bivalent/Poised TSS	A549	lung
41	chr14:36988000-36988800	Flanking Bivalent TSS/Enh	Brain Dorsolateral Prefrontal Cortex	brain
42	chr14:36988000-36988800	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
43	chr14:36988000-36988800	Flanking Bivalent TSS/Enh	Psoas Muscle	Psoas
44	chr14:36988000-36988800	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
45	chr14:36988000-36989000	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach
46	chr14:36988000-36989200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
47	chr14:36988000-36989400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr14:36988000-36989400	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
49	chr14:36988000-36989600	Active TSS	Right Atrium	heart
50	chr14:36988000-36990400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links